Skip to main content
Hybrigenics SA logo

Hybrigenics SA — Investor Relations & Filings

Ticker · ALHYG ISIN · FR0004153930 LEI · 9695003KQD0XMJYDX764 PA Professional, scientific and technical activities
Open in API
Filings indexed 145 across all filing types
Latest filing 2023-06-08 AGM Information
Country FR France
Listing PA ALHYG

About Hybrigenics SA

https://www.hybrigenics-services.com/

Hybrigenics Services is a specialized provider of technologies for studying molecular interactions. Its core offering is the ULTImate Y2H™ platform, a comprehensive Yeast Two-Hybrid system used to discover protein-protein interactions, as well as interactions with DNA, RNA, and small molecules. This technology is applied to drug discovery for target deconvolution and identifying molecular glues. A second key service is the Hybribody platform, which leverages a proprietary synthetic library for the custom selection, validation, and optimization of single-domain antibodies (VHHs/Nanobodies). The company serves clients in fundamental research, pharmaceutical R&D, and agroscience.

Recent filings

Filing Released Lang Actions
Convocation des actionnaires à l'assemblée générale annuelle ordinaire et extraordinaire du 28 juin 2023
AGM Information Classification · 98% confidence The document is titled "Convocation des actionnaires à l'assemblée générale annuelle ordinaire et extraordinaire du 28 juin 2023" (Notice to shareholders for the ordinary and extraordinary general meeting of June 28, 2023). It explicitly invites shareholders to an Annual General Meeting (AGM) and details the agenda, including approving the 2022 accounts and capital structure changes. This content directly relates to the materials and announcements surrounding the AGM. Therefore, the appropriate classification is AGM Information (AGM-R). The document length (2325 chars) is short, but it is the primary notice/convocation itself, not just an announcement that the notice exists, making AGM-R more specific than RPA or RNS.
2023-06-08 French
Résultats annuels 2022
Earnings Release Classification · 97% confidence The document is titled "Résultats annuels 2022" (Annual Results 2022) and presents the company's statutory accounts (comptes sociaux) for the year ended December 31, 2022, including key financial tables (revenue, operating result, net result, balance sheet data) and a discussion of subsidiary results and future outlook. This content strongly indicates a comprehensive annual financial report. Although it is presented as a press release summarizing the results, the depth of financial data provided (full year comparison, balance sheet details, subsidiary performance breakdown) suggests it is the primary disclosure of the annual figures. Since the document explicitly mentions the full 'rapport annuel 2022' is available elsewhere, this text functions as the official announcement of the annual results, which aligns best with the 'Annual Report' category (10-K) for comprehensive yearly performance disclosure, or potentially an 'Earnings Release' (ER) if it were only quarterly. Given the full-year focus and detailed financial tables, 10-K is the most appropriate classification for the content type, even if the format is a press release summarizing the statutory accounts. It is more detailed than a typical ER. FY 2022
2023-04-28 French
Visioconférence Hybrigenics destinée aux actionnaires et à tous les investisseurs individuels reprogrammée au jeudi 4 mai 2023 à 18h00
AGM Information Classification · 85% confidence The document is a press release announcing the rescheduling of a videoconference intended for shareholders and individual investors. The purpose of this videoconference is for the CEO to comment on the 'résultats annuels 2022' (2022 annual results) and strategic outlook, and to answer questions. Although it discusses annual results, the document itself is an announcement about a future event (the conference call) where the results will be discussed, not the full Annual Report (10-K) or the initial Earnings Release (ER). Since the event is a conference call for investors where Q&A is expected, and it is specifically about discussing results, it strongly aligns with the definition of a Call Transcript (CT) if the transcript were present, or an announcement leading up to it. However, the core content is the announcement of a meeting where results will be presented and discussed, which is closely related to investor communication surrounding results. Given the options, this is an announcement about an event that will likely generate a Call Transcript (CT). Since the document is short (2442 chars) and is announcing a future event where results will be discussed, it is not the full 10-K or ER. It is an announcement related to investor engagement. The closest fit among the provided options for an announcement related to an investor presentation/discussion event, especially one involving Q&A, is often related to the Call Transcript (CT) or Investor Presentation (IP). Since it explicitly mentions a 'Visioconférence' where the CEO will comment on annual results and answer questions, this is essentially an announcement for an earnings call. If the document were the transcript itself, it would be CT. As an announcement for the call, it is a form of investor communication. Given the context of discussing annual results and Q&A, it is most closely related to the event that generates a Call Transcript (CT). However, if we strictly follow the definitions, it is an announcement about a meeting, not the meeting itself or the results document. It is not a standard AGM-R, DEF 14A, or IP. Since it is an announcement about a call where results are discussed, and the document is short, it could potentially fall under RNS if no better fit exists. But because the event is explicitly a conference call for investors to discuss results and Q&A, it is highly related to the 'Call Transcript' (CT) category, even though this is the announcement *for* the call. In the absence of a specific 'Call Announcement' category, and given the focus on the call itself, I will classify it as related to the event type. A better fit might be an Investor Presentation (IP) if it were a slide deck, but this is a call announcement. Given the nature of the event (CEO commentary + Q&A), it is most analogous to the event that produces a CT. I will use RNS as the fallback if the event type is not covered, but since it is an announcement about a specific investor event, RNS is too general. Let's re-evaluate: It is an announcement about a call to discuss annual results. This is often released as an ER or RPA. Since it's an announcement about a call, RPA (Report Publication Announcement) is plausible if the call is treated as the 'publication' event. However, the content is about the *event* itself. I will classify this as a Regulatory Filing (RNS) as it is a specific announcement that doesn't fit the core report types (10-K, IR, ER) or the specific meeting/voting types (AGM-R, DVA). It is an announcement of a future event. Revisiting the definitions: It is an announcement about a future event where results will be discussed. This is not a DEF 14A (Remuneration), DIRS (Insider Trading), or DIV (Dividend). It is an announcement of a shareholder/investor event. If it were the actual presentation slides, it would be IP. If it were the transcript, it would be CT. Since it's an announcement about the call, RNS is the safest general regulatory announcement category, or RPA if we consider the call itself a form of 'publication'. Given the focus on the call details, RNS is appropriate as a general announcement.
2023-04-27 French
Visioconférence destinée aux actionnaires d'Hybrigenics et à tous les investisseurs individuels le 28 avril 2023 à 14h30 à l'occasion de la publication des résultats annuels 2022
AGM Information Classification · 85% confidence The document is a press release dated April 24, 2023, announcing a videoconference scheduled for April 28, 2023, specifically to discuss the 'publication des résultats annuels 2022' (publication of the 2022 annual results). The content focuses on inviting shareholders to a call where the CEO will comment on the annual results and answer questions. This is an announcement about an event related to the release of financial results, but it is not the full Annual Report (10-K) itself, nor is it the initial Earnings Release (ER) which usually contains the figures. Since the event is centered around the annual results discussion and Q&A, it strongly relates to the context of an earnings call or a meeting where results are presented. However, the document itself is an invitation/announcement for a shareholder meeting/call related to the annual results. Given the options, this is most closely related to an event where results are discussed, which often accompanies an Earnings Release (ER) or is a specific event like an AGM (AGM-R). Since it explicitly mentions commenting on 'résultats annuels 2022' and includes a Q&A session for investors, it functions as a communication surrounding the annual results announcement. If the full results were attached, it might be RPA, but this is an invitation to a call. The closest fit among the options for a scheduled event to discuss results is often linked to the Earnings Release (ER) context, or if it were a formal meeting, AGM-R. Since it's an invitation to a specific call to discuss the annual results, and not the results document itself, and it's not explicitly an AGM, the most appropriate classification for an announcement related to the release of annual performance data, especially when structured as a call for investors, is often grouped with the Earnings Release (ER) context, or if it's a formal meeting, AGM-R. Given the structure (invitation to a call to discuss annual results), it is highly indicative of an event surrounding the annual results disclosure. If the document were the transcript, it would be CT. Since it is the announcement of the event where results are discussed, and it is not a general regulatory filing (RNS), I will classify it based on the subject matter: annual results discussion. Since it is an invitation to a call, and not the results themselves, and it is not explicitly an AGM, I will lean towards the context of the results announcement. However, if we strictly follow the definitions, this is an announcement of a shareholder event related to results. If this were a transcript, it would be CT. If it were the results document, it would be 10-K or IR. Since it is an invitation to a call where the CEO will comment on the annual results, it is a communication event. Given the options, and the focus on annual results, it is strongly related to the 10-K cycle, but the document type is an announcement of a call. I will select AGM-R as it is a formal meeting/conference call for shareholders regarding annual performance, which is a common structure for AGM follow-ups or dedicated results meetings.
2023-04-24 French
Hybrigenics présente les avancées de sa filiale B Cell Design, spécialisée dans le développement d'anticorps artificiels
Regulatory Filings Classification · 100% confidence The document is a press release dated March 22, 2023, detailing strategic updates regarding Hybrigenics' subsidiary, B Cell Design, focusing on its artificial antibody development and market positioning (diagnostic sector). It discusses an acquisition, technological advantages, industrialization plans, and current commercialization efforts. This type of announcement, providing operational and strategic updates outside of mandatory periodic financial filings (like 10-K or IR), typically falls under general corporate news or investor relations updates. Since it is not a formal financial report (10-K, IR, ER, MRQ), a specific management discussion (MDA), or a capital event (CAP, SHA), it is best classified as a general Regulatory Filing (RNS) as it is a public announcement of corporate activity, or potentially an Investor Presentation (IP) if it were structured as slides, but given the press release format, RNS is the most appropriate general category for non-standard, material corporate news.
2023-03-22 French
Hybrigenics poursuit son plan de développement
Capital/Financing Update Classification · 98% confidence The document is a press release dated March 15, 2023, detailing strategic updates, investment milestones (€4M), and a significant financing event: the extension of a capital financing line (BEORA contract) with IRIS. It discusses future plans, profitability goals, and mentions upcoming communication of strategy milestones to shareholders. This content strongly aligns with announcements related to corporate financing activities and strategic updates, rather than a full annual report (10-K), an earnings release (ER), or a formal dividend notice (DIV). The specific mention of extending a financing contract (BEORA) points directly to 'Capital/Financing Update'. Given the short length (3224 chars) and the nature of the announcement (a press release detailing financial structuring), CAP is the most appropriate classification.
2023-03-15 French

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.